Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FMBJK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,438
Award facts
- Contract value 100% obligated
- $8,438.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Dupixent 300 mg/2 mL pens in 2 mL quantities with a ceiling value of $8,438.03. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements on a competitive basis. Dupixent is a specialized biologic medication used primarily for treating moderate-to-severe atopic dermatitis and other inflammatory conditions, reflecting the company's role in supplying specialty medications to support military and federal healthcare operations. The firm fixed-price structure and rapid completion timeline indicate this is a routine replenishment order within the broader pharmaceutical supply chain serving defense medical operations.
Quick answers
Who was awarded contract SPE2DB26FMBJK?
SPE2DB26FMBJK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FMBJK worth?
The government has obligated $8,438 on SPE2DB26FMBJK.
Is contract SPE2DB26FMBJK an order under another contract?
Yes. SPE2DB26FMBJK is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMBJK competed?
The extent of competition for SPE2DB26FMBJK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award